- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03658265
Effects of Exercise Training at Different Timeline on Shoulder Dysfunction After Breast Cancer Modified Radical Mastectomy
Effect of Exercise Training at Different Timeline on Shoulder Dysfunction in Patients After Breast Cancer Modified Radical Mastectomy: A Randomized Controlled Trial
Study Overview
Status
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430070
- Zhongnan Hospital of Wuhan University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Between the ages of 25 and 75 years;
- Diagnosed with breast cancer by pathological diagnosis, the time of diagnosis and the time of inclusion are less than 6 weeks;
- Patients undergoing modified radical mastectomy: mastectomy includes unilateral total breast or breast-conserving surgery, as well as dissection of the affected axillary lymph nodes, but does not include sentinel lymph node biopsy;
- Postoperative chemotherapy or radiation therapy according to the condition;
- No other malignant tumors within 5 years;
- No physical therapy related contraindications;
- Signing informed consent.
Exclusion Criteria:
- The result of SLNB is negative who did not receive ALND;
- Received breast reconstruction surgery (prosthesis, latissimus dorsi, etc.);
- Combined tumor metastasis with other tissues and organs (liver, kidney, lung, brain, etc.);
- Combined severe heart disease, cerebrovascular disease, and mental illness;
- Patients with shoulder joint dysfunction before surgery;
- Unable to understand the rehabilitation training program provided by doctors or physiotherapists.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 7 days SIE plus 4 weeks PRE
Participants in this group will start shoulder isotonic exercise 7 days after surgery and begin progressive resistance exercise 4 weeks after surgery.
|
Shoulder isotonic exercise (SIE):exercise methods for shortening and relaxing the muscles around the shoulder joint. Progressive resistance exercise (PRE):A training method that gradually increases the resistance, which will increase the muscle capacity. |
Experimental: 7 days SIE plus 3 weeks PRE
Participants in this group will start shoulder isotonic exercise 7 days after surgery and begin progressive resistance exercise 3 weeks after surgery.
|
Shoulder isotonic exercise (SIE):exercise methods for shortening and relaxing the muscles around the shoulder joint. Progressive resistance exercise (PRE):A training method that gradually increases the resistance, which will increase the muscle capacity. |
Experimental: 3 days SIE plus 4 weeks PRE
Participants in this group will start shoulder isotonic exercise 3 days after surgery and begin progressive resistance exercise 4 weeks after surgery.
|
Shoulder isotonic exercise (SIE):exercise methods for shortening and relaxing the muscles around the shoulder joint. Progressive resistance exercise (PRE):A training method that gradually increases the resistance, which will increase the muscle capacity. |
Experimental: 3 days SIE plus 3 weeks PRE
Participants in this group will start shoulder isotonic exercise 3 days after surgery and begin progressive resistance exercise 3 weeks after surgery.
|
Shoulder isotonic exercise (SIE):exercise methods for shortening and relaxing the muscles around the shoulder joint. Progressive resistance exercise (PRE):A training method that gradually increases the resistance, which will increase the muscle capacity. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Constant-Murley Shoulder Score
Time Frame: 1 weeks after surgery
|
The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100.
Higher scores indicate better shoulder function.
|
1 weeks after surgery
|
Constant-Murley Shoulder Score
Time Frame: 3 weeks after surgery
|
The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100.
Higher scores indicate better shoulder function.
|
3 weeks after surgery
|
Constant-Murley Shoulder Score
Time Frame: 6 weeks after surgery
|
The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100.
Higher scores indicate better shoulder function.
|
6 weeks after surgery
|
Constant-Murley Shoulder Score
Time Frame: 9 weeks after surgery
|
The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100.
Higher scores indicate better shoulder function.
|
9 weeks after surgery
|
Constant-Murley Shoulder Score
Time Frame: 12 weeks after surgery
|
The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100.
Higher scores indicate better shoulder function.
|
12 weeks after surgery
|
Constant-Murley Shoulder Score
Time Frame: 18 weeks after surgery
|
The shoulder function was evaluated by the total score of the Constant-Murley Shoulder Score Questionnaire, which ranged from 0 to 100.
Higher scores indicate better shoulder function.
|
18 weeks after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Active and passive range of motion
Time Frame: 3 days,1, 2, 3, 6, and 9 weeks after surgery
|
In the standard position, the mobility of the shoulder flexion, extension, external rotation and internal rotation was measured by using protractor.
The range of flexion is 0-180°, the range of extension is 0-180°, the range of external rotation is 0-90°, and the range of internal rotation is measured.
0-70°.
The assessments will be performed in the active and passive state separately.
|
3 days,1, 2, 3, 6, and 9 weeks after surgery
|
Shoulder joint muscle strength
Time Frame: 3 days, 3, 6, 9 weeks after surgery
|
In the standard position, the muscle strength of the flexion, extension, external rotation and internal rotation of the shoulder joint were assessed according to the "manual muscle test standard".
|
3 days, 3, 6, 9 weeks after surgery
|
The power of gripping
Time Frame: 1, 3 days and 1, 2, 3, 6, and 9 weeks after surgery
|
In the standard position, the grip of the patient's palm is measured using a dynamometer.
|
1, 3 days and 1, 2, 3, 6, and 9 weeks after surgery
|
EORTC QLQ BR23 Breast Cancer Quality of Life Questionnaire
Time Frame: 1, 3, 9, 12, 18 weeks after surgery
|
The quality of life assessment of breast cancer patients was evaluated by the total score of the EORTC QLQ BR23 Breast Cancer Quality of Life Questionnaire, which ranged from 0 to 92.
Higher scores indicate better quality of life.
|
1, 3, 9, 12, 18 weeks after surgery
|
SF-36 Health status questionnaire
Time Frame: 1, 3, 9, 12, 18 weeks after surgery
|
The quality of life assessment of breast cancer patients was evaluated by the total score of the SF-36 Health status questionnaire, which ranged from 0 to 92.
Higher scores indicate better quality of life.
|
1, 3, 9, 12, 18 weeks after surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analogue Scale (VAS)
Time Frame: 1 day, 3 days, 1 week, 2 weeks after surgery
|
Visual Analogue Scale(VAS): Used to assess the degree of pain.
Draw a 10 cm horizontal line on the paper.
One end of the horizontal line is 0, indicating no pain; the other end is 10, indicating severe pain; the middle part indicates different degrees of pain.
|
1 day, 3 days, 1 week, 2 weeks after surgery
|
Sum drainage from chest wall and axillary after operation.
Time Frame: 1 day, 3 days, 1 week, 2 weeks after surgery
|
The postoperative drainage was the total volume of the chest wall drainage tube and the underarm drainage tube.
The volume measurement and recording in the drainage bag were observed daily by the nurse.
|
1 day, 3 days, 1 week, 2 weeks after surgery
|
Upper limb circumference
Time Frame: Preoperative 3, 9, 12,18 weeks after surgery
|
Preoperative 3, 9, 12,18 weeks after surgery
|
|
body weight
Time Frame: Preoperative, 3, 9 weeks after surgery
|
Preoperative, 3, 9 weeks after surgery
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRE2018013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Susan G. Komen Breast Cancer FoundationCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer
Clinical Trials on 7 days SIE plus 4 weeks PRE
-
Hospital de Santa Maria, PortugalFundação para a Ciência e a TecnologiaCompletedCondition of Fetal Growth or Malnutrition (Diagnosis)Portugal
-
University of OxfordShoklo Malaria Research Unit; Chiangrai Prachanukroh HospitalRecruiting
-
Ege UniversityCompleted
-
Fox Chase Cancer CenterCardinal HealthRecruitingOropharynx CancerUnited States
-
Mansoura UniversityCompletedAcute CholecystitisEgypt
-
University Health Network, TorontoActive, not recruitingAxial SpondyloarthritisCanada
-
Weill Medical College of Cornell UniversityCompletedTonsillectomyUnited States
-
Inesa AstramskaitėCompleted
-
USDA Grand Forks Human Nutrition Research CenterCompleted
-
National Institute of Allergy and Infectious Diseases...CONRADCompleted